lacto-n-neotetraose has been researched along with Diabetic Feet in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farhadihosseinabadi, B; Ghanbarian, H; Kazemi, B; Mozafari, M; Niknejad, H; Salimi, M; Samadikuchaksaraei, A | 1 |
1 other study(ies) available for lacto-n-neotetraose and Diabetic Feet
| Article | Year |
|---|---|
Inducing type 2 immune response, induction of angiogenesis, and anti-bacterial and anti-inflammatory properties make Lacto-n-Neotetraose (LNnT) a therapeutic choice to accelerate the wound healing process.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacterial Infections; Diabetes Mellitus, Experimental; Diabetic Foot; Drug Evaluation, Preclinical; Gastrointestinal Tract; Humans; Lymphokines; Mice; Milk, Human; Models, Biological; Neovascularization, Physiologic; Oligosaccharides; Th2 Cells; Wound Healing | 2020 |